NanoOmics Lab

The NanoOmics Lab is dedicated to generating and disseminating fundamental knowledge at the intersection of nanotechnology, omics sciences, and blood biomarker discovery. We aim to develop nanotechnology tools to enhance early disease detection and personalize medicine, with a particular focus on neurodegeneration and neurooncology.

Nature Communications

Plasma-to-tumour tissue integrated proteomics using nano-omics for biomarker discovery in glioblastoma

Xinming Liu, Hanan Abmanhal-Masarweh, Olivia Iwanowytsch, Emmanuel Okwelogu, Kiana Arashvand, Konstantina Karabatsou, Pietro I D'Urso, Federico Roncaroli, Kostas Kostarelos, Thomas Kisby*, Marilena Hadjidemetriou*

Nature Nanotechnology

First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses

Jack Andrews^, Shruti Joshi^, Evangelos Tzolos, Maaz Syed, Hayley Cuthbert, Livia Crica, Neus Lozano, Emmanuel Okwelogu, Jennifer Raftis, Lorraine Bruce, Craig Poland, Rodger Duffin, Paul Fokkens, John Boere, Daan Leseman, Ian Megson, Phil D. Whitfield, Kerstin Ziegler, Seshu Tammireddy, Marilena Hadjidemetriou, Cyrill Bussy, Flemming Cassee, David Newby, Kostas Kostarelos*, Mark Miller*

Nature Reviews Materials

In vivo biomolecule corona and the transformation of a foe into an ally for nanomedicine

Marilena Hadjidemetriou, Morteza Mahmoudi*, Kostas Kostarelos*

Nanoscale

The lipidomic profile of the nanoparticle-biomolecule corona reflects the diversity of plasma lipids

Lana Papafilippou, Anna Nicolaou, Alexandra Kendall, Dolores Camacho-Muñoz, Marilena Hadjidemetriou*

Emmanuel has graduated with his PhD!

Olivia presents at the GJBRC 'Navigating brain tumour diagnosis' conference in Manchester